Cargando…
A novel targeted co-delivery nanosystem for enhanced ovarian cancer treatment via multidrug resistance reversion and mTOR-mediated signaling pathway
BACKGROUND: Multidrug resistance (MDR) is the main challenge of successful chemotherapy for ovarian cancer patients, with 50% to 75% of ovarian cancer patients eventually relapsed due to it. One of the effective strategies for treating MDR and improving therapeutic efficiency of ovarian cancer is to...
Autores principales: | Wang, Xueqin, Xiong, Tiandi, Cui, Miao, Li, Na, Li, Qin, Zhu, Li, Duan, Shaofeng, Wang, Yunlong, Guo, Yuqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8697442/ https://www.ncbi.nlm.nih.gov/pubmed/34949180 http://dx.doi.org/10.1186/s12951-021-01139-1 |
Ejemplares similares
-
Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery
por: Grande, Fedora, et al.
Publicado: (2019) -
Reversing autism by targeting downstream mTOR signaling
por: Wang, Hansen, et al.
Publicado: (2013) -
Direct and Reverse Pluronic Micelles: Design and Characterization of Promising Drug Delivery Nanosystems
por: Naharros-Molinero, Almudena, et al.
Publicado: (2022) -
Esomeprazole Alleviates Cisplatin Resistance by Inhibiting the AKT/mTOR Pathway in Ovarian Cancer Cells
por: Duan, Jingya, et al.
Publicado: (2023) -
Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells
por: Zhao, Xuanping, et al.
Publicado: (2023)